Building Wealth For Those Who Follow!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
:) Have a great weekend ORIONS
If he's this mad on Fridays , I'd hate to see him on Mondays !
AVNR kaboomed to 4.52!!
AVNR at 4.35 from 4.28 entry. Looking good imo
AVNR taking a beating! Maybe a good time to enter at 4.28?
EPAZ looking good Dev :)
Looking at NAVB. Maybe picking up a starter here then adding tomorrow?
Sup guys... Still holding MFST and looking for that explosion !!
Coming soon
1,000 FOLLOWERS!!! Weeeeeeee
ETRM going to go soon! May catalyst :)
LMAO!! I guess they have their bases covered. Only in pink sheets :)
Loaded heavy here. Looking for a good run soon IMO !
Will Social security really run out of money?
With millions of Americans counting on Social Security to be there when they retire, news that the program could run out of money is scary. But many question whether a looming Social Security funding shortfall is really something to worry about.
In the following segment from their video guide to investment planning, Motley Fool director of investment planning Dan Caplinger talks with Fool markets/IP bureau chief Mike Klesta about Social Security's coming funding challenges. Dan notes that one reason why so many people take their Social Security benefits early is that they think that the program might not be able to pay them later in life. But he thinks that's a mistake, because worst-case scenarios still have Social Security having enough money to pay full benefits for decades to come even without any changes to the program. Moreover, even under current law, retirees would still get about 75% of their benefits even after the Social Security Trust Fund is depleted. Dan concludes that with the likelihood of at least some action from lawmakers before automatic benefit reductions would take place, there's little reason to worry that Social Security won't be there when you need it.
Your real worry about your Social Security What's much smarter than worrying needlessly is for you to take the time and make sure that Social Security gives you all the benefits that you're entitled to receive. We want to help. In our brand-new free report, " Make Social Security Work Harder for You ," our retirement experts give their insight on making the key decisions that will help ensure a more comfortable retirement for you and your family. Click here to get your copy today.
I think you're right lucky9 :)
Good morning board and happy Friday!
Great point sheff and thanks for that .
I took out half those today :)
33k buy at 4.78 right at the close. Looking good for a test at 5$'s IMO.
Great day indeed!
SING looking to move on Tuesday !
MFST strong buy IMO!!
I don't see MFST on that list LC.. Isn't it still a buy?
Very nice and straight forward! Thank you.
So what exactly does that mean? I'm not sure I understand that clearly..
The fact they still hold shares should be a positive sign IMO. Everything that I've read makes me very bullish on IDRA so I'll add more .
Any opinion on the 4.25 after hours trades? Hope it doesn't stay there .
MFST looked very nice today! News and kabooom!!!
MFST getting ready to BLOW!!!!!
ASKH looking interesting. Might look for some in the morning.
Baker bros own a bunch of shares here! I'll be adding more tomorrow.
Great day for AVNR! Looking to test 4$'s this week IMO.
AVNR looks to be building higher.
IFON looking good.
Avanir Pharmaceutical Inc. (NASDAQ: AVNR) is a name with real upside to buy at Piper Jaffray. Shares of the company rose last week after the company said sales of its drug Nuedexta were strong in the fiscal first quarter. Avanir said it expects to report between $23.3 million and $23.9 million in net sales of Nuedexta. According to FactSet, analysts expected $22.7 million on average. The analyst also think the company will prevail in its current litigation involving the drug. The Piper Jaffray price target is $13. The Thomson/First Call estimate is $8.19. Avanir closed Friday at $3.44. A move to the target would be more than a 300% gain.
Training for a new position at work and noticed my trading account got crushed :(
Wowza....
Sounds great sheff!
APPY closed at 2.47 hod and now 2.49 after hours. Looks good for tomorrow IMO.
APPY - Took a 5k starter here.
Fredspal may god bless you and heal your heart till you meet your love again.
CPRX - Took a position yesterday at 2.02
Chart looks ready IMO.